Pharmacokinetics & Pharmacodynamics of Diethylcarbamazine (DEC)+ Albendazole (ALB) + Ivermectin (IVE)

NCT02845713 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Wuchereria Bancrofti Infection

Interventions

DRUG: Ivermectin, Diethylcarbamazine Albendazole (IDA)

Sponsor

University Hospitals Cleveland Medical Center

Collaborators

[object Object]